New Drug Designations – February 2024

Shots:PharmaShots' designation report provides a concise overview of several drugs and their designations by the US FDA, and EC. This month’s report includes designations allotted to 13 small molecules, 20 biologics, and 2 devices SN Bioscience’s SNB-101 received ODD from the US FDA for the treatment of pancreatic cancer based on preclinical results. It…

BySenior EditorMarch 28, 2024

INSIGHTS+

New Drug Designations – January 2024

Shots: PharmaShots' designation report provides a concise overview of several drugs and their designations by the US FDA, EC, and China’s NMPA. This month’s report includes 13 small molecules, 7 devices, 3 biologics ADC, 3 gene therapy, 1 antineoplastics, 1 protein, 1 peptide, 1 recombinant enzyme & 1 vaccine NRx Pharmaceuticals’ NRX-101 small molecule, focused…

BySenior EditorFebruary 20, 2024

INSIGHTS+

A Complete Account of FDA Approvals in 2023

Shots: 2023 remained a year of notable approvals by the US FDA. Around 55 drugs were approved, by the US FDA in 2023 PharmaShots, in an enlightening report, brings a summarized analysis of the approved drugs. The most explored section remains Oncology, Neurology, and Hematology  For the complete report with analysis, reach out to us…

BySenior EditorFebruary 1, 2024

INSIGHTS+

New Drug Designations – December 2023

Shots: PharmaShots' designation report provides a concise overview of several drugs and their designations by the US FDA, EC, and China’s NMPA. This month’s report includes 6 biological drugs, 10 small molecules, 5 cell and gene therapies, 1 recombinant fusion protein, 1 peptide and 2 devices Neurocrine Biosciences’ Crinecerfont, focused on the treatment of Congenital Adrenal Hyperplasia…

BySenior EditorJanuary 25, 2024

THOUGHTSPOT

Role of Real World Evidence in Pharma (RWE in Pharma)

Shots: Real-world evidence (RWE) aims to mitigate the limitations of randomized controlled trials (RCTs) by keeping a constant vigil on the safety and effectiveness of drugs in real-world settings Phrases such as Real-world data, Randomized Controlled Trials, and Real-World Evidence hold a degree of paramount importance when it comes to safeguarding the health of individuals…

BySaurabh ChaubeyDecember 12, 2023

TOP 20

Top 20 Monoclonal Antibodies Based on 2022 Total Revenue

Shots:Monoclonal antibodies are transforming therapeutics through their highly efficient targeting mechanisms. There is a wide range of uses for monoclonal antibodies, including diagnosis, therapy, and researchIn 2021, the monoclonal antibody therapy market size was valued at $178.5B and is envisioned to reach $451.89B by 2028, displaying a CAGR of 14.1%. Humira was the…

ByPrince GiriSeptember 26, 2023

THOUGHTSPOT

How Psychotropic Medications Impact Your Health

Psychotropic medications can have a powerful effect on both physical and mental health. They work by altering or affecting chemical processes in our brains, affecting mood, behavior, and physical well-being.It is essential to be aware of how psychotropic medications can impact your health, both positively and negatively. The effects of psychotropic medications vary from…

ByLauren CordellMay 19, 2023

New Drug Designations – February 2024

New Drug Designations – January 2024

A Complete Account of FDA Approvals in 2023

New Drug Designations – December 2023

Role of Real World Evidence in Pharma (RWE in Pharma)

Top 20 Monoclonal Antibodies Based on 2022 Total Revenue

How Psychotropic Medications Impact Your Health

Contact US

OUR INFORMATION

FOLLOW US